Associated Papers
MMS22L is a novel key actor of normal and pathological erythropoiesis.
Colin E et al.
Hemasphere, 2025
Severe Neonatal Anemia with Multi-Organ Failure, Extreme Placentomegaly, and Placental Megaloblastic Erythroblastosis as Features in Identifying Congenital Dyserythropoietic Anemia Type 1: A Case Report.
Roose O et al.
Neonatology, 2025
Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patients.
Marra R et al.
American Journal of Hematology, 2024
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).
Niss O et al.
Blood Cells, Molecules & Diseases, 2021
Clinical and genetic features of congenital dyserythropoietic anemia (CDA).
Moreno-Carralero MI et al.
European Journal of Haematology, 2018
Select a paper to view details